France Dried Blood Spot Collection Cards Market

France Dried Blood Spot Collection Cards Market Size & Forecast:

• France Dried Blood Spot Collection Cards Market Size 2025: USD 15.22 Million
• France Dried Blood Spot Collection Cards Market Size 2033: USD 24.08 Million
• France Dried Blood Spot Collection Cards Market CAGR: 5.93%
• France Dried Blood Spot Collection Cards Market Segments: Product Type (Protein Saver Cards, Standard DBS Cards), By Application (Newborn Screening, Infectious Disease Testing, Therapeutic Drug Monitoring).

To learn more about this report,  Download Free Sample Report

France Dried Blood Spot Collection Cards Market Summary:

The France Dried Blood Spot Collection Cards Market size is estimated at USD 15.22 Million in 2025 and is anticipated to reach USD 24.08 Million by 2033, growing at a CAGR of 5.93% from 2026 to 2033.The growth of the market depends on the increasing implementation of DBS cards which health programs use for newborn screening and infectious disease testing and therapeutic drug monitoring. The primary market segment for DBS card applications continues to be newborn screening because the technology provides healthcare professionals with a less invasive and more affordable and effective solution to identify medical conditions in newborns. 

The market in France benefits from three factors which include the increasing number of infectious diseases and the rise in preterm births and the heightened understanding of the need for early medical assessment and disease prevention methods. The market expansion receives its support from government backing and existing insurance frameworks and active research development programs. The various functions of DBS cards which include their simple storage and transport methods and their ability to support remote testing have led to their increased usage in forensic work and epidemiological research which has turned these fields into the fastest developing segments. The presence of sample contamination hazards and the implementation of strict regulatory requirements will create small obstacles to progress according to experts who predict that technological progress will solve these problems in the future.

Key Market Trends & Insights:

• Strong Growth in Newborn Screening Programs France’s expanding newborn screening initiatives are creating an increased need for dried blood spot (DBS) collection cards which serve as essential tools for detecting metabolic and genetic disorders through their minimally invasive testing capabilities that receive government healthcare support and parental and medical professional awareness.

• Increasing Use in Infectious Disease Testing DBS cards have become more common for diagnosing infectious diseases which include testing for HIV and hepatitis. The products can be collected and stored and transported easily which makes them suitable for use in extensive surveillance efforts that French public health systems use to monitor and detect diseases.

• Rising Demand for Chronic Disease Monitoring The increasing number of people who suffer from chronic diseases like cardiovascular and neurological disorders has resulted in higher demand for DBS cards which provide therapeutic drug monitoring. The cards enable users to collect samples from home which helps patients follow treatment plans while doctors can monitor their progress during extended periods.

• Scientists are developing new DBS card materials and analytical methods which include better filter paper and mass spectrometry connection system to produce more accurate and trustworthy testing results. The new developments enable researchers to use the technology in clinical diagnostics and research studies while pharmaceutical companies can use it for medicine monitoring.

• The growing demand for remote healthcare services which focus on patient needs is driving hospitals in France to start using DBS tests. People can collect samples at home while using telemedicine which allows them to receive medical tests without visiting hospitals and makes healthcare services available to people from various backgrounds.

France Dried Blood Spot Collection Cards Market Segmentation

By Product Type

• Protein Saver Cards:The specialized DBS card Proteinsaver cards serve the purpose of maintaining proteins enzymes and metabolites from dried blood samples. The cards demonstrate exceptional performance in clinical diagnostics because they can detect minute quantities while keeping test samples intact for extended periods. The system enables researchers to conduct biochemical and metabolic evaluations which makes it suitable for their standard medical procedures.

• Standard DBS Cards:Standard DBS cards are general-purpose filter paper cards used for collecting and storing dried blood samples. Their low cost combined with their user-friendly design makes them suitable for numerous testing and research activities which encompass infectious disease detection and medication testing. The cards are frequently utilized in remote testing situations because they can be easily transported without the need for cold storage facilities.

By Application

• Newborn Screening: The largest application segment in France belongs to newborn screening because public health programs require early identification of metabolic genetic and endocrine disorders through mandated testing. The use of DBS cards establishes ideal testing conditions because the method requires minimal invasive procedures while enabling secure sample storage and dependable sample delivery. The segment generated its peak revenue value through its recent business operations.

• Infectious Disease Testing:The use of DBS cards extends to diagnostic testing for infectious diseases which include HIV and hepatitis and respiratory infections. The ability to maintain samples at room temperature enables these products to function effectively in remote areas which lack resources for disease monitoring and epidemiological research.

• Therapeutic Drug Monitoring:DBS cards function as the standard measurement tool for drug levels in patients who need long-term therapeutic drug monitoring. The technology allows healthcare providers to collect patient samples without causing significant pain to patients, which makes it suitable for use in clinical research and chronic health condition treatment. The segment experiences growth because more people want personalized medical solutions which allow them to monitor their health from home.

To learn more about this report,  Download Free Sample Report

Country Insights

The dried blood spot collection cards market in France has experienced continuous development through two main factors which include the country's advanced healthcare system and its government efforts to promote preventive health care. The country has established comprehensive newborn screening programs which depend on DBS cards to detect metabolic and genetic disorders at an early stage. Hospitals and diagnostic laboratories can easily collect and transport samples through DBS technology because it provides both accessible and efficient features which are especially useful in areas with few laboratory facilities.

There is a rising trend for healthcare facilities to use DBS cards not only for newborn screening but also for infectious disease testing and therapeutic drug monitoring. The demand for healthcare services is increasing because people need to understand chronic diseases like HIV and hepatitis and the importance of continuous monitoring for personalized medicine. DBS cards have become the preferred option for healthcare providers in both urban and rural areas of France because these cards require only a small amount of blood and can be stored at room temperature.

The market receives additional support from two factors which include increased funding for biotechnology research and the growth of diagnostic service operations. The private and public healthcare sectors are working together to develop affordable diagnostic methods, which has led manufacturers to create new protein saver DBS cards and standard DBS cards. The DBS collection card market in France will experience continuous expansion during the next few years because of the country's dedication to preventive healthcare and its use of decentralized diagnostic methods.

Recent Development News

September 2025: The French national newborn screening program will introduce three new rare genetic disease tests which use dried blood spot samples from Guthrie cards on September 2025. The implementation marks an improvement to current health programs which deliver medical care to infants during their first weeks of life.

April 2026: New Clinical Study Evaluates DBS Method for Hepatitis Delta Virus Detection, The DBS card study for hepatitis delta virus (VHD) detection started in France when a clinical study began in April 2026. The study aims to confirm DBS sampling method for both serological testing and molecular testing which will support its use in testing various infectious diseases.

Key France Dried Blood Spot Collection Cards Market Company Insights

The France DBS collection cards market is shaped by a blend of global diagnostics leaders and specialty material manufacturers that together drive innovation, quality, and broad application coverage. Major players such as PerkinElmer, Inc., GE Healthcare, Ahlstrom‑Munksjö, QIAGEN N.V., and F. Hoffmann‑La Roche Ltd hold strong positions because they maintain extensive portfolios of DBS solutions which serve newborn screening and infectious disease testing and therapeutic drug monitoring. The companies conduct research and development activities to create better card products which meet regulatory requirements and work with automated laboratory systems that perform sample collection and analysis in clinical and research environments.

Bio‑Rad Laboratories, Thermo Fisher Scientific, Merck KGaA, Danaher, Shimadzu Corporation, Agilent Technologies, Abbott Laboratories, QIAGEN, BD Biosciences, Eppendorf, and Promega emerge as major contributors because they supply diagnostic systems and scientific instruments and chemical-based products which boost the effectiveness of DBS collection systems. Their combined presence strengthens the competitive landscape, which encourages product diversification and strategic partnerships and establishes market presence in new regions to drive ongoing market expansion throughout France and Europe.

Company List

• PerkinElmer
• GE Healthcare
• Ahlstrom-Munksjö
• Roche
• Bio‑Rad Laboratories
• Thermo Fisher Scientific
• Merck KGaA
• Danaher
• Shimadzu
• Agilent Technologies
• Abbott Laboratories
• QIAGEN
• BD Biosciences
• Eppendorf
• Promega

France Dried Blood Spot Collection Cards Market Report Segmentation

By Product Type

• Protein Saver Cards
• Standard DBS Cards

By Application

• Newborn Screening
• Infectious Disease Testing
• Therapeutic Drug Monitoring